Agreement signedAgreed 3 Oct 2022

Alexion Pharmaceuticals, Inc. /
LogicBio Therapeutics, Inc.

Alexion Pharmaceuticals, Inc. agrees to buy LogicBio Therapeutics, Inc.

Terms
Not stated
Stage
Agreement signed
Buy side: Alexion Pharmaceuticals, Inc.
Buy sideAlexion Pharmaceuticals, Inc.
Target: LogicBio Therapeutics, Inc.
TargetLogicBio Therapeutics, Inc.
Source · 3 Oct 2022
Buy side: Alexion Pharmaceuticals, Inc.
Buy sideAlexion Pharmaceuticals, Inc.
Target: LogicBio Therapeutics, Inc.
TargetLogicBio Therapeutics, Inc.
01 / BuyerAlexion Pharmaceuticals, Inc.
02 / TargetLogicBio Therapeutics, Inc.
01

What happened

Alexion Pharmaceuticals, Inc. agreed to acquire LogicBio Therapeutics, Inc., according to a filing dated Nov. 16, 2022.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Alexion Pharmaceuticals, Inc. agrees to buy LogicBio Therapeutics, Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

  2. Announced

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.